Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
Clinical trial NCT00030355 · WITHDRAWN
Trial details
- NCT number
- NCT00030355
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.